The University of Iowa

Multiple Modality Biomarker Prediction of Cognitive Impairment in Prospectively Followed De Novo Parkinson’s Disease

Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu I, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, Hawkins KA, Litvan I, Richard I, and Weintraub D on behalf of the Parkinson’s Progression Markers Initiative
PLoS ONE. 2017; 12 (5) e0175674.
PubMed: 
Projects: